CP expression was higher in GBM, LGG, ovarian cancer (OV), kidney renal clear cell carcinoma (KIRC), and other tumor tissue samples compared to paraneoplastic tissues (Figure 1A). This evidence concerns the gene CP and ovarian cancer.